We represented a multi-state behavioral health and addiction treatment company in evaluating and responding to a state medical board investigation involving allegations of Controlled Substances Act violations by one of the company’s providers. We advised the client regarding regulatory response strategies and compliance oversight measures. Following the investigation, the medical board took no action against either the client or the provider.